Early calcineurin inhibitors avoidance improves renal function in de novo heart transplant recipients: The results of a randomized controlled trial (SCHEDULE trial)
Andreassen, A. K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Raadegran, G.; Gude, E.; Solbu, D.; Sigurdardottir, V.; Dellgren, G.; Gullestad, L.
European Heart Journal 34(Suppl 1): 879-879
2013
ISSN/ISBN: 0195-668X DOI: 10.1093/eurheartj/eht308.879
Accession: 064308043
PDF emailed within 0-6 h: $19.90
Related References
Rashidi, M.; Esmaily, S.; Fiane, A.E.; Gustafsson, F.; Eiskjær, H.; Rådegran, G.; Dellgren, G. 2015: The Effect of Everolimus vs. Calcineurin Inhibitors on Surgical Complications: The Results of a De Novo Heart Transplant Randomized Controlled Trial (SCHEDULE Trial) Journal of Heart and Lung Transplantation 34(4): S132-S133Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjær, H.; Rådegran, G.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.; Gullestad, l. 2015: Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial Journal of Heart and Lung Transplantation 34(4): S129-S130
Relbo Authen, A.; Grov, I.; Karason, K.; Gustafsson, F.; Eiskjaer, H.; Rådegran, G.ör.; Gude, E.; Jansson, K.; Dellgren, G.ör.; Solbu, D.; Arora, S.; Andreassen, A.K.; Gullestad, L. 2017: Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE) Clinical Transplantation 31(9)
Bartfay, S. E.; Gude, E.; Sigurdardottir, V.; Andreassen, A. K.; Gullestad, L.; Andersson, B. 2013: Maintained cardiac reserve in heart transplant patients during early calcineurin inhibitor avoidance: a substudy of a randomised controlled trial (SCHEDULE trial) European Heart Journal 34(Suppl 1): P2181-P2181
Bartfay, S.; Gullestad, L.; Sigurdardottir, V.; Andreassen, A.K.; Gude, E.; Andersson, B. 2014: Maintained Cardiac Reserve in Heart Transplant Patients During Early Calcineurin Inhibitor Avoidance: A Substudy of a Randomised Controlled Trial (SCHEDULE Trial) Journal of Heart and Lung Transplantation 33(4): S173-S174
De Simone, P.; Nevens, F.; De Carlis, L.; Metselaar, H.J.; Beckebaum, S.; Saliba, F.; Jonas, S.; Sudan, D.; Fung, J.; Fischer, L.; Duvoux, C.; Chavin, K.D.; Koneru, B.; Huang, M.A.; Chapman, W.C.; Foltys, D.; Witte, S.; Jiang, H.; Hexham, J.M.; Junge, G. 2012: Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 12(11): 3008-3020
Andreassen, A.K.; Andersson, B.; Gustafsson, F.; Eiskjaer, H.; Rådegran, G.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.; Gullestad, L. 2016: Everolimus Initiation with Early Calcineurin Inhibitor Withdrawal in de Novo Heart Transplant Recipients: Three-Year Results from the Randomized SCHEDULE Study American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16(4): 1238-1247
Herlenius, G.; Felldin, M.; Nordén, G.; Olausson, M.; Bäckman, L.; Gustafsson, B.; Friman, S. 2010: Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial Transplantation Proceedings 42(10): 4441-4448
Van Dijk, M.; van Roon, A.M.; Said, M.Y.; Bemelman, F.J.; Homan van der Heide, J.J.; de Fijter, H.W.; de Vries, A.P.J.; Bakker, S.J.L.; Sanders, J.S.F. 2018: Long-term cardiovascular outcome of renal transplant recipients after early conversion to everolimus compared to calcineurin inhibition: results from the randomized controlled MECANO trial Transplant International: Official Journal of the European Society for Organ Transplantation 31(12): 1380-1390
Andreassen, A.K.; Broch, K.; Eiskjær, H.; Karason, K.; Gude, E.; Mølbak, D.; Stueflotten, W.; Gullestad, L. 2019: Blood Pressure in De Novo Heart Transplant Recipients Treated With Everolimus Compared With a Cyclosporine-based Regimen: Results From the Randomized SCHEDULE Trial Transplantation 103(4): 781-788
Woodle, E.; Marder, B.; Harler, M.; Vincenti, F.; Citterio, F.; Nori, U.; Grinyo, J. 2014: Renal Function at 4 Years in a Phase 2 Randomized Trial Evaluating Belatacept-Based Regimens with Simultaneous Calcineurin Inhibitor and Corticosteroid Avoidance in Kidney Transplant Recipients Transplantation 98: 114-115
Derthoo, D.; Van Caenegem, O.; De Pauw, M.; Nellessen, E.; Duerinckx, N.; Ciarka, A.; Droogné, W.; Van Cleemput, J.; Belmans, A.; Meyns, B.; Vanhaecke, J. 2014: A Randomized Trial of Everolimus Initiation and Calcineurin Inhibitor (CNI) Elimination in Stable Heart Transplant Recipients With Impaired Renal Function Journal of Heart and Lung Transplantation 33(4): S14-S15
Nashan, B.; Schemmer, P.; Braun, F.; Dworak, M.; Wimmer, P.; Schlitt, H. 2015: Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial Trials 16: 118
Gustafsson, F.; Andreassen, A.K.; Andersson, B.; Eiskjær, H.; Rådegran, G.ör.; Gude, E.; Jansson, K.; Solbu, D.; Karason, K.; Arora, S.; Dellgren, G.ör.; Gullestad, L. 2020: Everolimus Initiation with Early Calcineurin Inhibitor Withdrawal in de Novo Heart Transplant Recipients: Long-term Follow-up from the Randomized SCHEDULE Study Transplantation 104(1): 154-164
Murbraech, K.; Holdaas, H.; Massey, R.; Undset, L.H.; Aakhus, S. 2014: Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial Transplantation 97(2): 184-188
Murbraech, K.; Massey, R.; Undset, L.H.; Midtvedt, K.; Holdaas, H.; Aakhus, S. 2015: Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial Clinical Transplantation 29(8): 678-684
&na, &na; ,, 2006: Efficacy and Safety of Conversion from Calcineurin Inhibitors to Sirolimus versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients: 18-Month Results from a Randomized, Open-Label Comparative Trial Transplantation 82(Suppl 2): 412-413
Rolid, K.; Andreassen, A.K.; Yardley, M.; Bjørkelund, E.; Authen, A.R.; Grov, I.; Gude, E.; Broch, K.; Gullestad, L.; Nytrøen, K. 2020: Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients - 3-year Results from the HITTS Randomized Controlled Trial Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 39(4s): S224-S225
Rolid, K.; Andreassen, A.K.; Yardley, M.; Gude, E.; Bjørkelund, E.; Authen, A.R.; Grov, I.; Pettersen, K.I.; Dall, C.H.; Karason, K.; Broch, K.; Gullestad, L.; Nytrøen, K. 2020: High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trial Health and Quality of Life Outcomes 18(1): 283
Masetti, M.; Montalti, R.; Rompianesi, G.; Codeluppi, M.; Gerring, R.; Romano, A.; Begliomini, B.; Di Benedetto, F.; Gerunda, G.E. 2010: Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(10): 2252-2262